Temporal control of gene deletion in sensory ganglia using a tamoxifen-inducible Advillin-Cre-ERT2 recombinase mouse
Temporal control of gene deletion in sensory ganglia using a tamoxifen-inducible Advillin-Cre-ERT2 recombinase mouse
Background:
Tissue-specific gene deletion has proved informative in the analysis of pain pathways. Advillin has been shown to be a pan-neuronal marker of spinal and cranial sensory ganglia. We generated BAC transgenic mice using the Advillin promoter to drive a tamoxifen-inducible CreERT2 recombinase construct in order to be able to delete genes in adult animals. We used a floxed stop ROSA26LacZ reporter mouse to examine functional Cre expression, and analysed the behaviour of mice expressing Cre recombinase.
Results:
We used recombineering to introduce a CreERT2 cassette in place of exon 2 of the Advillin gene into a BAC clone (RPCI23-424F19) containing the 5' region of the Advillin gene. Transgenic mice were generated using pronuclear injection. The resulting AvCreERT2 transgenic mice showed a highly specific expression pattern of Cre activity after tamoxifen induction. Recombinase activity was confined to sensory neurons and no expression was found in other organs. Less than 1% of neurons showed Cre expression in the absence of tamoxifen treatment. Five-day intraperitoneal treatment with tamoxifen (2 mg per day) induced Cre recombination events in ≈90% of neurons in dorsal root and cranial ganglia. Cell counts of dorsal root ganglia (DRG) from transgenic animals with or without tamoxifen treatment showed no neuronal cell loss. Sensory neurons in culture showed ≈70% induction after 3 days treatment with tamoxifen. Behavioural tests showed no differences between wildtype, AvCreERT2 and tamoxifen-treated animals in terms of motor function, responses to light touch and noxious pressure, thermal thresholds as well as responses to inflammatory agents.
Conclusions:
Our results suggest that the inducible pan-DRG AvCreERT2 deleter mouse strain is a useful tool for studying the role of individual genes in adult sensory neuron function. The pain phenotype of the Cre-induced animal is normal; therefore any alterations in pain processing can be unambiguously attributed to loss of the targeted gene.
Lau, J
110111bb-650d-4542-b129-19539b7b594b
Minett, MS
d767767a-4b0f-4090-a715-70a936fc37c6
Zhao, Jing
3ef68480-9eec-48a2-aa09-f355cb1eff05
Dennehy, U
0aa24107-1cb7-4f19-b652-57ba9d478e4e
Wang, Fan
900d033e-8a89-454f-a9fe-05f3c642906c
Wood, John N.
d46f4f46-d7dc-43c9-b65e-b5cc899eaa2a
Bogdanov, Yury D.
0c970999-e191-4f1b-90d9-7bf25a5d5b4b
1 December 2011
Lau, J
110111bb-650d-4542-b129-19539b7b594b
Minett, MS
d767767a-4b0f-4090-a715-70a936fc37c6
Zhao, Jing
3ef68480-9eec-48a2-aa09-f355cb1eff05
Dennehy, U
0aa24107-1cb7-4f19-b652-57ba9d478e4e
Wang, Fan
900d033e-8a89-454f-a9fe-05f3c642906c
Wood, John N.
d46f4f46-d7dc-43c9-b65e-b5cc899eaa2a
Bogdanov, Yury D.
0c970999-e191-4f1b-90d9-7bf25a5d5b4b
Lau, J, Minett, MS, Zhao, Jing, Dennehy, U, Wang, Fan, Wood, John N. and Bogdanov, Yury D.
(2011)
Temporal control of gene deletion in sensory ganglia using a tamoxifen-inducible Advillin-Cre-ERT2 recombinase mouse.
Molecular Pain, 7.
(doi:10.1186/1744-8069-7-100).
Abstract
Background:
Tissue-specific gene deletion has proved informative in the analysis of pain pathways. Advillin has been shown to be a pan-neuronal marker of spinal and cranial sensory ganglia. We generated BAC transgenic mice using the Advillin promoter to drive a tamoxifen-inducible CreERT2 recombinase construct in order to be able to delete genes in adult animals. We used a floxed stop ROSA26LacZ reporter mouse to examine functional Cre expression, and analysed the behaviour of mice expressing Cre recombinase.
Results:
We used recombineering to introduce a CreERT2 cassette in place of exon 2 of the Advillin gene into a BAC clone (RPCI23-424F19) containing the 5' region of the Advillin gene. Transgenic mice were generated using pronuclear injection. The resulting AvCreERT2 transgenic mice showed a highly specific expression pattern of Cre activity after tamoxifen induction. Recombinase activity was confined to sensory neurons and no expression was found in other organs. Less than 1% of neurons showed Cre expression in the absence of tamoxifen treatment. Five-day intraperitoneal treatment with tamoxifen (2 mg per day) induced Cre recombination events in ≈90% of neurons in dorsal root and cranial ganglia. Cell counts of dorsal root ganglia (DRG) from transgenic animals with or without tamoxifen treatment showed no neuronal cell loss. Sensory neurons in culture showed ≈70% induction after 3 days treatment with tamoxifen. Behavioural tests showed no differences between wildtype, AvCreERT2 and tamoxifen-treated animals in terms of motor function, responses to light touch and noxious pressure, thermal thresholds as well as responses to inflammatory agents.
Conclusions:
Our results suggest that the inducible pan-DRG AvCreERT2 deleter mouse strain is a useful tool for studying the role of individual genes in adult sensory neuron function. The pain phenotype of the Cre-induced animal is normal; therefore any alterations in pain processing can be unambiguously attributed to loss of the targeted gene.
This record has no associated files available for download.
More information
e-pub ahead of print date: 1 January 2011
Published date: 1 December 2011
Additional Information:
© 2011 Lau et al.
Identifiers
Local EPrints ID: 469799
URI: http://eprints.soton.ac.uk/id/eprint/469799
ISSN: 1744-8069
PURE UUID: f0de3044-3800-4bf3-ab9c-e8e308214728
Catalogue record
Date deposited: 26 Sep 2022 16:39
Last modified: 17 Mar 2024 03:37
Export record
Altmetrics
Contributors
Author:
J Lau
Author:
MS Minett
Author:
Jing Zhao
Author:
U Dennehy
Author:
Fan Wang
Author:
John N. Wood
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics